AbbVie Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
AbbVie Inc
TickerABBV
CIK #0001551152
CUSIP00287Y109
SectorLife Sciences - Pharmaceutical Preparations
Address1 North Waukegan Road, North Chicago, IL 60064
Source [EDGAR]
CIK Filing 2011 - 2024
[0001551152] 10-K
[0001551152] 10-Q
[0001551152] 3
[0001551152] 4
[0001551152] 8-K
[0001551152] D
[0001551152] SC 13D
[0001551152] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
AbbVie Inc Exicure Inc [2017-10-06] 5.5
Capital Research Global Investors AbbVie Inc [2016-11-10] 10.0
AbbVie Inc Reata Pharmaceuticals Inc [2016-06-06] 17.93
Capital Research Global Investors AbbVie Inc [2014-02-13] 6.3
Vanguard Group Inc AbbVie Inc [2014-02-10] 5.17
AbbVie Inc Enanta Pharmaceuticals Inc [2014-02-07] 5.97
BlackRock Inc AbbVie Inc [2014-01-28] 6.6
Form 3/4/5 Filer 2011 - 2024
Strom Carrie C
AbbVie Inc.
Alpern Robert J
Burnside William HL
Freyman Thomas C
Waddell Frederick H
Tilton Glenn F
Roberts Rebecca B
Rapp Edward J
Meyer Melody B
Austin Roxanne S
Hart Brett J
Sorg Elaine K.
Siatis Perry C
Stewart Jeffrey Ryan
Buckbee Kevin K
Gonzalez Richard A
Hudson Thomas J
Richmond Timothy J
Michael Robert A.
Reents Scott T
Durkin Brian L
Saleki-Gerhardt Azita
Severino Michael
Gosebruch Henry O
Liddy Edward M
Schumacher Laura J
Alban Carlos
Donoghoe Nicholas
Chase William J
Hurwich Thomas A
Reata Pharmaceuticals Inc
Roberts Roy S
Leonard John M
Abbott Laboratories
Linder Greg W
Form 13F Holdings
Firm Period DFND Voting Shares
Vanguard Group Inc [2023-03-31] SOLE 0.0 152,617,303.0
BlackRock Inc. [2023-03-31] SOLE 124,915,890.0 138,721,510.0
State Street Corp [2023-03-31] DFND 66,655,946.0 77,026,437.0
JPMorgan Chase & Co [2023-03-31] DFND 49,605,619.0 57,361,815.0
Capital International Investors [2023-03-31] DFND 42,690,272.0 42,748,362.0
Capital Research Global Investors [2023-03-31] DFND 35,712,762.0 35,714,367.0
Geode Capital Management LLC [2023-03-31] DFND 33,990,266.0 34,045,021.0
Morgan Stanley [2023-03-31] DFND 11,929,713.0 31,427,994.0
Bank of America Corp /DE/ [2023-03-31] DFND 5,681,503.0 22,246,052.0
Charles Schwab Investment Management Inc [2023-03-31] SOLE 21,536,638.0 21,536,656.0
Northern Trust Corp [2023-03-31] DFND 6,605,471.0 21,322,995.0
Bank of New York Mellon Corp [2023-03-31] DFND 15,904,742.0 19,026,610.0
Price T Rowe Associates Inc /MD/ [2023-03-31] SOLE 6,484,296.0 15,048,505.0
Ameriprise Financial Inc [2023-03-31] DFND 0.0 14,717,788.0
Janus Henderson Group PLC [2023-03-31] DFND 0.0 13,494,736.0
FMR LLC [2023-03-31] DFND 10,435,436.0 12,885,486.0
UBS Group AG [2023-03-31] DFND 0.0 12,563,239.0
Legal & General Group Plc [2023-03-31] DFND 9,891,750.0 11,886,553.0
Nuveen Asset Management LLC [2023-03-31] DFND 11,374,216.0 11,376,099.0
Goldman Sachs Group Inc [2023-03-31] DFND 9,516,479.0 10,782,788.0
Wells Fargo & Company/MN [2023-03-31] DFND 3,045,150.0 9,906,084.0
Royal Bank of Canada [2023-03-31] DFND 8,641,927.0 9,106,923.0
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt [2023-03-31] DFND 7,059,568.0 8,873,905.0
Amundi [2023-03-31] DFND 8,651,864.0 8,652,207.0
Invesco Ltd. [2023-03-31] DFND 0.0 8,095,258.0
Franklin Resources Inc [2023-03-31] DFND 7,855,124.0 8,082,959.0
Vanguard Group Inc [2023-03-31] DFND 0.0 7,829,790.0
T. Rowe Price Investment Management, Inc. [2023-03-31] SOLE 1,984,600.0 7,597,503.0
Citadel Advisors LLC [2023-03-31] DFND 7,480,043.0 7,480,043.0
Swiss National Bank [2023-03-31] SOLE 7,018,410.0 7,018,410.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com